Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transforaminal triamcinolone versus dexmedetomidine for radicular low back pain
IRCT201312037984N12Phase 3Completed
- Sponsor
- Research Council of Iran University of Medical Sciences
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of triamcinolone and dexmedetomidine in chronic low back pain (CLBP) and lumbosacral radiculopathy (2 arms), sponsored by Research Council of Iran University of Medical Sciences. Started Sep 2017; status: completed.
02
Drugs
triamcinolonedexmedetomidine
03
Conditions
chronic low back pain (CLBP)lumbosacral radiculopathy
Beyond the preview
Go deeper on IRCT201312037984N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201312037984N12.